Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVROBIO (AVRO)

AVROBIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVRO
DateTimeSourceHeadlineSymbolCompany
27/02/202415:50PR Newswire (US)Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
23/02/202421:00Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVROAVROBIO Inc
06/02/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202400:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202400:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
06/02/202400:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
01/02/202419:25PR Newswire (US)Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
30/01/202421:47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
30/01/202421:07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
30/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
30/01/202414:05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
30/01/202413:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
30/01/202413:00Business WireAVROBIO and Tectonic Therapeutic Announce MergerNASDAQ:AVROAVROBIO Inc
09/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
03/11/202320:15Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:AVROAVROBIO Inc
10/08/202321:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
12/07/202312:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
12/07/202312:00Business WireAVROBIO to Explore Strategic AlternativesNASDAQ:AVROAVROBIO Inc
03/07/202318:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
14/06/202322:20Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVROAVROBIO Inc
12/06/202312:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
12/06/202312:00Business WireAVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 MillionNASDAQ:AVROAVROBIO Inc
09/06/202321:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
08/06/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202321:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202321:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
08/06/202321:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
07/06/202317:07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
05/06/202321:25Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
 Showing the most relevant articles for your search:NASDAQ:AVRO